Cargando…

A rare case of carbimazole-induced hepatitis in a patient with Graves’ disease

Although carbimazole-induced hepatitis is rare, clinicians should be aware of this potential complication and offer alternative treatment early.

Detalles Bibliográficos
Autores principales:	Burgin, Sarah, Zanetto, Ulises, Cooney, Rachel, Basu, Ansu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589077/ https://www.ncbi.nlm.nih.gov/pubmed/26464807 http://dx.doi.org/10.1177/2054270415602827

Ejemplares similares

Carbimazole-induced cholestatic hepatitis in Graves’ disease
por: Kota, Sunil K., et al.
Publicado: (2013)

Carbimazole-induced agranulocytosis
por: Mohan, Anisha, et al.
Publicado: (2015)

Carbimazole-Resistant Grave’s Thyrotoxicosis is a Diagnostic and Therapeutic Dilemma, Case Report with Literature Review
por: Ata, Fateen, et al.
Publicado: (2023)

Radioiodine therapy in patients with Graves’ disease and the effects of prior carbimazole therapy
por: Karyampudi, Arun, et al.
Publicado: (2014)

Carbimazole Induced Pleural Effusion: A Case Report
por: Das, Gautam, et al.
Publicado: (2012)

Carbimazole-induced Anaphylactic Shock: A Case Report
por: Keyal, Niraj Kumar, et al.
Publicado: (2019)

Carbimazole induced nephrotoxicity
por: Rajesh, Reza, et al.
Publicado: (2021)

Carbimazole induced rhabdomyolysis
por: O’Donnell, Niamh, et al.
Publicado: (2021)

Carbimazole-Induced Jaundice in Thyrotoxicosis: A Case Report
por: Maliyakkal, Abdul Majeed, et al.
Publicado: (2021)

A suspected case of carbimazole-associated torsades de pointes
por: Bagchi, Chiranjib, et al.
Publicado: (2010)

Psychosis Following Carbimazole-induced Acute Alteration of Hyperthyroid Status
por: Gowda, Guru S., et al.
Publicado: (2017)

Agoitrous Graves’ Hyperthyroidism with Markedly Elevated Thyroid Stimulating Immunoglobulin Titre displaying Rapid Response to Carbimazole with Discordant Thyroid Function
por: Kon, Yin Chian, et al.
Publicado: (2020)

Carbimazole induced acute generalised exanthematous pustulosis
por: Kadambi, Madhavi, et al.
Publicado: (2015)

Carbimazole (Neo-Mercazole) in Thyrotoxicosis
por: Boyd, M. W. J.
Publicado: (1959)

Carbimazole Embryopathy and Choanal Atresia
por: Raveenthiran, V
Publicado: (2014)

Graves’ Disease with Pancytopenia and Hepatic Dysfunction: A Rare Case Presentation
por: Behera, Kishore Kumar, et al.
Publicado: (2019)

Severe Hypothyroxinemia in a Young Adult with Carbimazole-Treated T3-Predominant Graves’ Hyperthyroidism, Reversed with L-Thyroxine Loading Immediately Post-Total Thyroidectomy
por: Chiang, Brenda, et al.
Publicado: (2021)

Structural Refinement of Carbimazole by NMR Crystallography
por: Scarperi, Andrea, et al.
Publicado: (2021)

A Case of Aplasia Cutis Congenita in the Setting of Maternal Carbimazole Use in the First Trimester
por: McGrath, Colin, et al.
Publicado: (2023)

Anti-Thyroid Drugs-Related Myopathy: Is Carbimazole the Real Culprit?
por: Tsang, Chiu Chi, et al.
Publicado: (2015)

Carbimazole inhibits TNF-α expression in Fat-induced hypothyroidism
por: Tripathi, Yamani Bhusan, et al.
Publicado: (2014)

Carbimazole-Induced Agranulocytosis in a Previously Stable Patient: A Case Report and Literature Review
por: Khan, Zahid, et al.
Publicado: (2022)

Life-threatening haematological complication occurring in a cat after chronic carbimazole administration
por: Mosca, Andrea, et al.
Publicado: (2016)

Gastroschisis Due to Maternal Exposure to Carbimazole in A Term Neonate
por: Asfour, Suzan S, et al.
Publicado: (2022)

Correction: Carbimazole-Induced Agranulocytosis in a Previously Stable Patient: A Case Report and Literature Review
por: Khan, Zahid, et al.
Publicado: (2023)

Insulin autoimmune syndrome as a cause of recurrent hypoglycemia in a carbimazole user: a case report from Nepal
por: Pant, Vivek, et al.
Publicado: (2019)

Rare presentation of Graves’ disease with myalgia: A case report
por: Kurihara, Masaru, et al.
Publicado: (2021)

A CASE OF AUTOIMMUNE HEPATITIS WITH GRAVES’ DISEASE TREATED BY PROPYLTHIOURACIL
por: SATO, IKUKO, et al.
Publicado: (2011)

Long-term carbimazole pretreatment reduces the efficacy of radioiodine therapy
por: Shivaprasad, C., et al.
Publicado: (2015)

Graves’ disease coexisting with resistance to thyroid hormone: a rare case
por: Sun, Hongping, et al.
Publicado: (2017)

Management of Psychosis Associated with Graves' Disease: A Rare Case Report
por: Williams, Ozge Ceren Amuk, et al.
Publicado: (2022)

Graves’ disease overlapping with chronic hepatitis B and methimazole-induced liver injury and autoimmune hepatitis: a case report
por: Zheng, Meifang, et al.
Publicado: (2022)

Weight homeostasis & its modulators in hyperthyroidism before & after treatment with carbimazole
por: Dutta, Pinaki, et al.
Publicado: (2012)

Graves' disease: A rare fate of Hashimoto's thyroiditis
por: Jadhav, Rahul, et al.
Publicado: (2020)

Cholestatic Hepatitis in Graves' Disease: A Diagnostic Challenge
por: Haddaden, Metri, et al.
Publicado: (2021)

Familial dysalbuminemic hyperthyroxinemia combined with Graves’ disease: a rare case report
por: Li, Yuanmeng, et al.
Publicado: (2023)

Histological Changes in Autoimmune Hepatitis with Graves' Disease: A Child Case Report
por: Yamada, Mamiko, et al.
Publicado: (2017)

LBODP100 A Rare Case Of Pembrolizumab Induced Graves’ Disease
por: Alqaisi, Sura, et al.
Publicado: (2022)

Primary Hepatic Angiosarcoma: A Rare Liver Malignancy − Varying Manifestations but Grave Prognosis
por: Rujeerapaiboon, Natthapat, et al.
Publicado: (2020)

Guillain–Barré Syndrome developing in a patient with Graves’ Disease
por: Majumder, Anirban, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8fv972seubsoke5gbm6q9efvk1